SHANE CARTER: Open Payments
NPI 1245955822 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,301 in 95 payments from 11 companies in 2025. Trend: 2023 $215 · 2024 $3,302 · 2025 $2,301
Food & beverage: $2,296Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $638 |
| E.R. Squibb & Sons, L.L.C. | 17 | $338 |
| Janssen Pharmaceuticals, Inc | 15 | $299 |
| Braeburn Inc. | 5 | $296 |
| Otsuka America Pharmaceutical, Inc. | 10 | $272 |
| Supernus Pharmaceuticals, Inc. | 15 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
Products named: VRAYLAR, COBENFY, REXULTI, BRIXADI, SPRAVATO, Qelbree, CAPLYTA, Auvelity.
Industry payments across UT — which companies pay providers there.
